Related Experiment Video
Updated: Jan 20, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
Pre-clinical Model of Cardiac Donation after Circulatory Death
Henry Aceros1, Leyla Joulali2, Mélanie Borie1
1Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM).
Insights
This study presents a rat model for evaluating heart preservation after circulatory death (DCD). The protocol allows testing cardioprotective strategies to reduce injury, improving donor heart viability for transplantation.
Area of Science:
- Cardiovascular Research
- Transplantation Biology
- Ischemia-Reperfusion Injury Models
Background:
- Increasing demand for cardiac transplantation is limited by donor organ scarcity.
- Organ donation after circulatory death (DCD) offers a potential solution but faces challenges due to warm ischemia and tissue injury.
- Routine use of DCD hearts in transplantation is limited by concerns over organ quality and post-transplant outcomes.
Purpose of the Study:
- To develop and validate a detailed rat model for assessing cardiac function after DCD.
- To enable continuous monitoring of heart function and evaluation of cardioprotective interventions.
- To facilitate research into strategies mitigating ischemia-reperfusion injury in DCD hearts.
Main Methods:
- Induction of circulatory death in Lewis rats by ventilation cessation.
- Initiation of warm ischemic time upon systolic blood pressure drop (<30 mmHg).
- Ex vivo heart perfusion using a Langendorff system with continuous functional assessment and biochemical/histological injury analysis.
Main Results:
- A reproducible protocol for DCD heart assessment was established.
- The model allows modulation of warm ischemic time to induce varying degrees of injury.
- Cardiac troponin T levels and infarct size quantify heart injury, while pressure monitoring assesses functional recovery.
Conclusions:
- This DCD heart model provides a platform for evaluating cardioprotective strategies.
- The protocol mimics clinical DCD practices and allows for assessment of interventions.
- Findings from this model can inform strategies to improve the viability of DCD donor hearts for clinical transplantation.
Abstract:
Cardiac transplantation demand is on the rise; nevertheless, organ availability is limited due to a paucity of suitable donors. Organ donation after circulatory death (DCD) is a solution to address this limited availability, but due to a period of prolonged warm ischemia and the risk of tissue injury, its routine use in cardiac transplantation is seldom seen. In this manuscript we provide a detailed protocol closely mimicking current clinical practices in the context of DCD with continuous monitoring of heart function, allowing for the evaluation of novel cardioprotective strategies and interventions to decrease ischemia-reperfusion injury. In this model, the DCD protocol is initiated in anesthetized Lewis rats by stopping ventilation to induce circulatory death. When systolic blood pressure drops below 30 mmHg, the warm ischemic time is initiated. After a pre-set warm ischemic period, hearts are flushed with a normothermic cardioplegic solution, procured, and mounted onto a Langendorff ex vivo heart perfusion system. Following 10 min of initial reperfusion and stabilization, cardiac reconditioning is continuously evaluated for 60 min using intraventricular pressure monitoring. A heart injury is assessed by measuring cardiac troponin T and the infarct size is quantified by histological staining. The warm ischemic time can be modulated and tailored to develop the desired amount of structural and functional damage. This simple protocol allows for the evaluation of different cardioprotective conditioning strategies introduced at the moment of cardioplegia, initial reperfusion and/or during ex vivo perfusion. Findings obtained from this protocol can be reproduced in large models, facilitating clinical translation.
More Related Videos
Related Concept Videos
Anatomy of the Circulatory System
Cardiac Catheterization I: Pre-Procedure Overview
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

